The Pyruvate Dehydrogenase Complex as a Target for Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
239-245
Author(s):
Peter W. Stacpoole, Renius Owen and Terence R. Flotte
Is Impaired Flow-Mediated Dilatation of the Brachial Artery a Cardiovascular Risk Factor?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
107-109
Author(s):
Stefan Agewall
Endothelial Therapy of Atherosclerosis and its Risk Factors
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
111-121
Author(s):
Tobias Traupe, Jana Ortmann, Klaus Munter and Matthias Barton
Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
123-133
Author(s):
C. P. Tiefenbacher and J. Kreuzer
Vulnerable Atherosclerotic Plaque: Clinical Implications
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
183-204
Author(s):
Jinho Shin, Jay E. Edelberg and Mun K. Hong
Diabetes, the Renin-Angiotensin System and Heart Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
225-238
Author(s):
Hoong Sern Lim and Gregory Y.H. Lip
From CHD Susceptibility Genes to New Therapeutics
Journal:
Current Pharmacogenomics
Volume:
1
Page:
111-125
Author(s):
Gerd Schmitz, Thomas Langmann, Susanne Heimerl and Christoph Schumacher
Non-Peptidic Inhibitors of Cysteine Proteases
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
361-373
Author(s):
T. Schirmeister and U. Kaeppler
Preface (Hot Topic: Medicinal Strategies in the Treatment of Obesity Guest Editor: Akio Inui)
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
3
Page:
ii-ii
Author(s):
Akio Inui
Glucagon-like Peptides, the Central Nervous System, and the Regulation of Energy Homeostasis
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
3
Page:
73-80
Author(s):
Julie A. Lovshin and Daniel J. Drucker